CD4 and COVID-19: The aim of our study was to evaluate the magnitude of immunological response to sequential BNT 162b2 mRNA vaccines in PLWH regarding demographic and clinical factors including CD4 status, viral load, COVID-19 morbidity, and hospitalization.